Balanced approach can help initial outcomes: analysis of initial 50 cases of a new liver transplantation program in East Asia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Dong-Sik | - |
dc.contributor.author | Yu, Young-Dong | - |
dc.contributor.author | Jung, Sung-Won | - |
dc.contributor.author | Yang, Kyung-Sook | - |
dc.contributor.author | Seo, Yeon-Seok | - |
dc.contributor.author | Um, Soon-Ho | - |
dc.contributor.author | Suh, Sung-Ock | - |
dc.date.available | 2020-11-02T17:46:11Z | - |
dc.date.issued | 2014-07 | - |
dc.identifier.issn | 2288-6575 | - |
dc.identifier.issn | 2288-6796 | - |
dc.identifier.uri | https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/9162 | - |
dc.description.abstract | Purpose To evaluate patient triage pattern and outcomes according to types of liver transplantation as part of a new liver transplant program developed in an East Asian country with a limited number of deceased donors. Methods Medical records of initial 50 liver transplantations were reviewed retrospectively. Results Twenty-nine patients underwent deceased donor liver transplantation (DDLT) and 21 patients underwent living donor liver transplantation (LDLT). Mean model for end-stage liver disease scores of recipients of DDLT and LDLT were 24.9 ± 11.6 and 13.1 ± 5.4, respectively (P < 0.0001). Twenty-eight patients had HCCs and 17 of them (60.7%) underwent LDLT, which was 80.9% of LDLTs. There were 2 cases of perioperative mortality; each was from DDLT and LDLT, respectively. Median follow-up was 18 months. Overall patient and graft survival rates at 6 months, 1 and 2 years were 95.7%, 93.4%, and 89.8%, respectively. There was no significant difference in survival between DDLT and LDLT. Overall recurrence-free survival rates of hepatocellular carcinoma (HCC) patients at 6 month, 1, and 2 years were 96.3%, 96.3%, and 90.3%, respectively. There was no significant difference in recurrence-free survival between DDLT and LDLT. Conclusion As a new liver transplant program with limited resource and waiting list, patients with critical condition could undergo DDLT whereas relatively stable patients with HCCs were mostly directed to LDLT. We recommend a balanced approach between DDLT and LDLT for initiating liver transplant programs. | - |
dc.format.extent | 6 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한외과학회 | - |
dc.title | Balanced approach can help initial outcomes: analysis of initial 50 cases of a new liver transplantation program in East Asia | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.4174/astr.2014.87.1.22 | - |
dc.identifier.scopusid | 2-s2.0-84904974116 | - |
dc.identifier.wosid | 000338176800005 | - |
dc.identifier.bibliographicCitation | Annals of Surgical Treatment and Research, v.87, no.1, pp 22 - 27 | - |
dc.citation.title | Annals of Surgical Treatment and Research | - |
dc.citation.volume | 87 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 22 | - |
dc.citation.endPage | 27 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001883112 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | LIVING DONOR | - |
dc.subject.keywordPlus | HEPATOCELLULAR-CARCINOMA | - |
dc.subject.keywordPlus | SINGLE-CENTER | - |
dc.subject.keywordPlus | SURVIVAL | - |
dc.subject.keywordPlus | GRAFT | - |
dc.subject.keywordAuthor | Liver transplantation | - |
dc.subject.keywordAuthor | Donor selection | - |
dc.subject.keywordAuthor | Liver transplantation program | - |
dc.subject.keywordAuthor | Outcome | - |
dc.subject.keywordAuthor | Survival | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265
COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.